Health / Medical Topics

    Anti-5T4 Antibody-Drug Conjugate PF-06263507

    An antibody-drug conjugate composed of an antibody directed against 5T4 and conjugated, via the stable linker maleimidocaproyl (mc), to the microtubule inhibitor monomethyl auristatin phenylalanine (MMAF), with potential antineoplastic activity. Upon administration, the antibody moiety of PF-06263507 selectively binds to cells expressing the 5T4 oncofetal antigen. After internalization and enzymatic cleavage of the immunoconjugate within the tumor cell cytosol, free MMAF binds to tubulin and inhibits its polymerization, which may result in G2/M phase arrest and tumor cell apoptosis. 5T4, a transmembrane glycoprotein, is overexpressed by a variety of cancer cell types; its expression is correlated with increased invasiveness. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    The branch of science concerned with origin and development of humans in all their physical, social, and cultural relationships.
    Generated by the actions of humans.
    Anthrax toxin receptor 1 (564 aa, ~63 kDa) is encoded by the human ANTXR1 gene. This protein plays a role in the…
    One of the key causes of anthrax virulence is the action of three specific factors produced by the bacterium Bacillus anthracis. Even…
    An infection caused by Bacillus anthracis bacteria. It may affect the lungs, gastrointestinal tract, or skin. Patients with lung infection present with…
    A substance that is based on the structure of anthraquinone and inhibits topoisomerase-II by intercalating into the DNA double strand.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact